C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2002
11/07/2002	US20020164652 Conformational antigens and antibodies recognizing said antigens, a process for the efficient generation of monoclonal antibodies to native or conformational antigens expressed or carried by eukaryotic cells, a process for the selection of conformational antigens, use of monoclonal antibodies for therapeutical, diagnostic or vaccine applications
11/07/2002	US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease
11/07/2002	US20020164642 Pool of immunoglobulin polypeptides for use in treating and preventing, inflammation, allergies, cancer, bacterial or viral infection, diabetes, arthritis, myasthenia gravis and autoimmune diseases
11/07/2002	US20020164618 Enzymes having high temperature polymerase activity and methods of use thereof
11/07/2002	US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002	US20020164585 Expression vector for use in the treatment of viral diseases
11/07/2002	US20020164347 Neoglycoproteins
11/07/2002	US20020164342 Recombinant cat allergen, Fel dI, expressed in baculovirus for diagnosis and treatment of cat allergy
11/07/2002	US20020164340 Multivalent MHC class II - peptide chimeras
11/07/2002	US20020164339 Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
11/07/2002	US20020164338 Combined approach to treatment of cancer with hCG vaccines
11/07/2002	US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002	US20020164336 Combination anti-selectin and immunosuppressant therapy
11/07/2002	US20020164335 Compositions and methods for the study and diagnosis of prion diseases
11/07/2002	US20020164334 Antibody-induced apoptosis
11/07/2002	US20020164333 Adenovirus gene particles; gene therapy
11/07/2002	US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002	US20020164328 Process for purifying antibody
11/07/2002	US20020164327 Pharmaceutical composition of F(ab)2 antibody fragments and a process for the preparation thereof
11/07/2002	US20020164326 Genetic engineering; administering immunoglobulins
11/07/2002	US20020164325 Regeneration of axons; central nervous systewm disorders
11/07/2002	US20020164324 Human serine protease
11/07/2002	US20020164319 Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
11/07/2002	US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002	DE10121255A1 Use of alpha 1-antichymotrypsin polypeptide or nucleic acids encoding the polypeptide, or of a cell expressing the polypeptide, or of antibody against the polypeptide, for diagnosing, treating or preventing poorly-healing wounds
11/07/2002	DE10120835A1 Batch method for preparing antibodies, useful as pharmaceuticals, by culturing cells with exchange of medium and removal of metabolic waste products
11/07/2002	DE10120816A1 New antibody specific for histamine receptor protein, useful for treating or preventing e.g. allergy or inflammation, also antigens for its preparation
11/07/2002	CA2715570A1 Cripto blocking antibodies and uses thereof
11/07/2002	CA2453675A1 Genes and proteins for the biosynthesis of lactimidomycin
11/07/2002	CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002	CA2445974A1 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof
11/07/2002	CA2445847A1 A molecular marker
11/07/2002	CA2445367A1 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002	CA2445349A1 Anti-cd40 monoclonal antibody
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002	CA2443719A1 Human fibroblast growth factor-related compositions
11/07/2002	CA2415339A1 Genes and proteins for the biosynthesis of polyketides
11/06/2002	EP1254913A1 Monoclonal antibodies against CK-MB
11/06/2002	EP1254666A1 Stable antibody compositions and injection preparations
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
11/06/2002	EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
11/06/2002	EP1254264A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254256A2 Novel nucleic acids and polypeptides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254248A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254241A2 Phosphatases
11/06/2002	EP1254239A2 Mammalian secreted group iii phospholipase a2
11/06/2002	EP1254238A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids
11/06/2002	EP1254236A2 Drug metabolizing enzymes
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
11/06/2002	EP1254225A2 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254219A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254218A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002	EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
11/06/2002	EP1254177A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS
11/06/2002	EP1254173A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254172A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254155A1 Mob-5/hmob-5 as a cancer diagnostic marker
11/06/2002	EP1254153A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254152A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254151A1 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254150A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1254147A2 Nucleic acids, proteins, and antibodies
11/06/2002	EP1253946A2 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
11/06/2002	EP1253942A1 Cd40-binding apc-activating molecules
11/06/2002	EP1253941A1 Pre-transplant accommodated organs resistant to anti-donor immunity
11/06/2002	EP1253928A2 Novel haptotactic peptides
11/06/2002	EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
11/06/2002	EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
11/06/2002	EP0773959B1 Adrenergic receptor
11/06/2002	EP0689550B1 Antimicrobial peptides from bovine neutrophils
11/06/2002	CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof
11/06/2002	CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
11/06/2002	CN1378594A T-cell receptor gamma alternate reading frame protein (TARP) and uses thereof
11/06/2002	CN1378552A Novel transcription factor BP1
11/06/2002	CN1378472A Synergy between low molecular weight heparin and platelet aggregation inhibitor, providing combination therapy for prevention and treatment of various thromboembolic disorders
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers
11/06/2002	CN1377965A Human peptide transport protein 2 coding sequence, preparing method and use
11/06/2002	CN1377964A China bee and hornet hemolysis peptide precursor gene and coded polypeptide and preparing method
11/06/2002	CN1377963A China bee sedative peptide precursor gene and its coded polypeptide and preparing method
11/06/2002	CN1377962A Asia-africa hornet sedative peptide precursor gene and its coded polypeptide and preparing method
11/06/2002	CN1377894A Process for preparing egg yolk anti-cancer antibody and its use
11/06/2002	CN1377891A Zinc finger protein from dendritic cell, its coding sequence and use
11/06/2002	CN1377885A Human signal conductive protein coding sequence, its preparing method and use
11/06/2002	CN1093881C Process for preparation of immunogens or diagnostic reagents, and method for obtaining immunogens or diagnostic reagents
11/05/2002	US6476213 Cloning and characterization of FLBA gene of H. pylori production of aflagellate
11/05/2002	US6476207 Genes and gene expression products that are differentially regulated in prostate cancer
11/05/2002	US6476198 Multispecific and multivalent antigen-binding polypeptide molecules
11/05/2002	US6476195 Secreted protein HNFGF20
11/05/2002	US6476193 NLK1 protein and NLK1 protein complexes
11/05/2002	US6475983 Water-soluble polypeptides having a high affinity for α and β interferons
11/05/2002	US6475791 Uses for DNA structure-specific recognition protein

1 ... 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 ... 1494